UCLA Research Program in Pharmaceutical Economics and Policy
Parent: UCLA
eScholarship stats: Breakdown by Item for April through July, 2024
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 5fg9n284 | Drug Evaluations: Type I vs. Type II Errors | 121 | 14 | 107 | 11.6% |
| 0d90459k | The Productivity of Health Care and Pharmaceuticals: An International Comparison | 29 | 10 | 19 | 34.5% |
| 5d8758z2 | The Pharmaceutical Research and Development Process, and its Costs | 24 | 11 | 13 | 45.8% |
| 7vz4h41m | Differences in Managed Care Drug Formularies: What Can Consumers Learn? | 23 | 11 | 12 | 47.8% |
| 46p5p6p4 | Do Managed Care Drug Formularies Signal Health Plan Coverage Generosity | 20 | 6 | 14 | 30.0% |
| 85s5w09k | Pharmaceutical Prices and Expenditures | 18 | 7 | 11 | 38.9% |
Disclaimer: due to the evolving nature of the web traffic we receive and the methods we use to collate it, the data presented here should be considered approximate and subject to revision.